Takashi Santou

792 citations

12 papers · 682 indexed · h-index 12

Co-authors: Naoyuki Kanzaki Nobuhiro Suzuki Tsuneo Yasuma Nobuyuki Negoro Yū Momose Yoshiyuki Tsujihata Miyuki Funami Masami Suzuki
Topics: Diabetes Treatment and Management (5 papers)Peptidase Inhibition and Analysis (4 papers)Pancreatic function and diabetes (4 papers)
Cited by: Endocrinology, Diabetes and Metabolism Molecular Biology Cancer Research
Journals: Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: Japan United States

In The Last Decade

Takashi Santou

12 papers receiving 672 citations

Peers

Countries citing papers authored by Takashi Santou

Since Specialization

Citations

This map shows the geographic impact of Takashi Santou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Santou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Santou more than expected).

Fields of papers citing papers by Takashi Santou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Santou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Santou. The network helps show where Takashi Santou may publish in the future.

Co-authorship network of co-authors of Takashi Santou

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Santou. A scholar is included among the top collaborators of Takashi Santou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Santou. Takashi Santou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate 2017 ·Bioorganic & Medicinal Chemistry ·Katsuji Aikawa,(unknown),Koji Ono,Noriyuki Habuka,Jason K. Yano,Keith P. Wilson,Hisashi Fujita,Hitoshi Kandori,Takahito Hara,Megumi Morimoto,Takashi Santou,Masuo Yamaoka,Masaaki Nakayama,Atsushi Hasuoka	36
2	Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Takenori Hitaka,Takashi Imada,Masami Yamada,Megumi Morimoto,(unknown),Takahito Hara,Masuo Yamaoka,Takashi Santou,Masaaki Nakayama,Yumi Imai,Noriyuki Habuka,Jason K. Yano,Keith P. Wilson,Hisashi Fujita,Atsushi Hasuoka	15
3	Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Oki,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	27
4	Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach 2016 ·Journal of Medicinal Chemistry ·Hiroshi Nara,(unknown),Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	42
5	Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site 2014 ·Bioorganic & Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	37
6	Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach 2014 ·Journal of Medicinal Chemistry ·Hiroshi Nara,Kenjiro Sato,(unknown),Hideyuki Mototani,Hideyuki Oki,Yoshio Yamamoto,Haruhiko Kuno,Takashi Santou,Naoyuki Kanzaki,Jun Terauchi,Osamu Uchikawa,Masakuni Kori	49
7	Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes 2012 ·Journal of Medicinal Chemistry ·Satoshi Mikami,Shuji Kitamura,Nobuyuki Negoro,Shinobu Sasaki,Masami Suzuki,Yoshiyuki Tsujihata,Takeshi Miyazaki,Ryo Ito,Nobuhiro Suzuki,Jun‐ichi Miyazaki,Takashi Santou,Naoyuki Kanzaki,Miyuki Funami,Toshimasa Tanaka,Tsuneo Yasuma,Yū Momose	47
8	Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent 2012 ·Journal of Medicinal Chemistry ·Nobuyuki Negoro,Shinobu Sasaki,Satoshi Mikami,Masahiro Ito,Yoshiyuki Tsujihata,Ryo Ito,Masami Suzuki,Koji Takeuchi,Nobuhiro Suzuki,Jun‐ichi Miyazaki,Takashi Santou,Tomoyuki Odani,Naoyuki Kanzaki,Miyuki Funami,Akio Morohashi,(unknown),Shin-ichiro Matsunaga,Tsuneo Yasuma,Yū Momose	68
9	Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists 2012 ·Journal of Medicinal Chemistry ·Nobuyuki Negoro,Shinobu Sasaki,Masahiro Ito,Shuji Kitamura,Yoshiyuki Tsujihata,Ryo Ito,Masami Suzuki,Koji Takeuchi,Nobuhiro Suzuki,Jun‐ichi Miyazaki,Takashi Santou,Tomoyuki Odani,Naoyuki Kanzaki,Miyuki Funami,Toshimasa Tanaka,Tsuneo Yasuma,Yū Momose	58
10	Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists 2011 ·Bioorganic & Medicinal Chemistry ·Satoshi Yamamoto,Nobuyuki Matsunaga,Takenori Hitaka,Masami Yamada,Takahito Hara,Jun‐ichi Miyazaki,Takashi Santou,Masami Kusaka,Masuo Yamaoka,Naoyuki Kanzaki,Shuichi Furuya,Akihiro Tasaka,(unknown),Mitsuhiro Ito	18
11	Design, Synthesis, and Biological Activity of Potent and Orally Available G Protein-Coupled Receptor 40 Agonists 2011 ·Journal of Medicinal Chemistry ·Shinobu Sasaki,Shuji Kitamura,Nobuyuki Negoro,Masami Suzuki,Yoshiyuki Tsujihata,Nobuhiro Suzuki,Takashi Santou,Naoyuki Kanzaki,Masataka Harada,Yasuhiro Tanaka,Makoto Kobayashi,Norio Tada,Miyuki Funami,Toshimasa Tanaka,Yoshio Yamamoto,K. Fukatsu,Tsuneo Yasuma,Yū Momose	75
12	Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist 2010 ·ACS Medicinal Chemistry Letters ·Nobuyuki Negoro,Shinobu Sasaki,Satoshi Mikami,Masahiro Ito,Masami Suzuki,Yoshiyuki Tsujihata,Ryo Ito,Ayako Harada,Koji Takeuchi,Nobuhiro Suzuki,Jun‐ichi Miyazaki,Takashi Santou,Tomoyuki Odani,Naoyuki Kanzaki,Miyuki Funami,Toshimasa Tanaka,Akifumi Kogame,Shin-ichiro Matsunaga,Tsuneo Yasuma,Yū Momose	210

About Takashi Santou

Takashi Santou is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 12 papers that have together received 682 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Peptidase Inhibition and Analysis (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (297 citations), Molecular Biology (437 citations) and Cancer Research (87 citations). Takashi Santou has collaborated with scholars based in Japan and United States. Frequent co-authors include Naoyuki Kanzaki, Nobuhiro Suzuki, Tsuneo Yasuma, Nobuyuki Negoro, Yū Momose, Yoshiyuki Tsujihata, Miyuki Funami, Masami Suzuki, Shinobu Sasaki and Jun‐ichi Miyazaki. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact